Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 10.63 USD 1.53% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Enfusion Inc?
Write Note

Enfusion Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Enfusion Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Enfusion Inc
NYSE:ENFN
Cash & Cash Equivalents
$35.6m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Salesforce Inc
NYSE:CRM
Cash & Cash Equivalents
$8B
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
25%
Palantir Technologies Inc
NYSE:PLTR
Cash & Cash Equivalents
$831m
CAGR 3-Years
-26%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Applovin Corp
NASDAQ:APP
Cash & Cash Equivalents
$502.2m
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Intuit Inc
NASDAQ:INTU
Cash & Cash Equivalents
$2.9B
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
18%
Adobe Inc
NASDAQ:ADBE
Cash & Cash Equivalents
$7.6B
CAGR 3-Years
26%
CAGR 5-Years
23%
CAGR 10-Years
21%
No Stocks Found

Enfusion Inc
Glance View

Market Cap
1.4B USD
Industry
Technology

Enfusion Inc. emerges as a notable player in the financial technology landscape, focusing on streamlining operations for investment managers through its cloud-native platform. Founded in Chicago, Enfusion began its journey to address the complexities faced by hedge funds and asset managers. By offering a cohesive suite of solutions, including portfolio management, order management, and accounting systems, Enfusion has carved a niche for itself. These integrated services enable clients to manage their entire investment lifecycle from a singular platform, eliminating the cumbersome need for multiple disconnected systems. This efficiency not only bolsters operational effectiveness but also offers significant cost savings, making Enfusion an attractive proposition for financial firms looking to modernize their back-office functions. The company generates revenue through a scalable, subscription-based model. Clients pay for access to Enfusion's robust software platform and the array of offerings it includes. This model provides Enfusion with a steady, predictable income stream, while also allowing clients the flexibility to tailor solutions according to their specific needs and scale, as necessary, without incurring significant upfront costs. Adding to its appeal, Enfusion provides comprehensive customer support and continuous software updates, ensuring that clients always work with the most current tools. By prioritizing innovation and client-centric services, Enfusion not only retains its existing customers but also continually attracts new ones in an industry that values both technological advancement and operational efficiency.

ENFN Intrinsic Value
9.4 USD
Overvaluation 12%
Intrinsic Value
Price

See Also

What is Enfusion Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
35.6m USD

Based on the financial report for Dec 31, 2023, Enfusion Inc's Cash & Cash Equivalents amounts to 35.6m USD.

What is Enfusion Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
37%

Over the last year, the Cash & Cash Equivalents growth was -43%. The average annual Cash & Cash Equivalents growth rates for Enfusion Inc have been 37% over the past three years .

Back to Top